Authors:
VANGILS FCJM
VANTEEFFELEN MEJM
NEELIS KJ
HENDRIKX J
BURGER H
VANLEEN RW
KNOL E
WAGEMAKER G
WOGNUM AW
Citation: Fcjm. Vangils et al., INTERLEUKIN-3 TREATMENT OF RHESUS-MONKEYS LEADS TO INCREASED PRODUCTION OF HISTAMINE-RELEASING CELLS THAT EXPRESS INTERLEUKIN-3 RECEPTORS AT HIGH-LEVELS, Blood, 86(2), 1995, pp. 592-597
Authors:
VANGILS FCJM
WESTERMAN Y
VISSER TP
BURGER H
VANLEEN RW
WAGEMAKER G
Citation: Fcjm. Vangils et al., NEUTRALIZING ANTIBODIES DURING TREATMENT OF HOMOLOGOUS NONGLYCOSYLATED IL-3 IN RHESUS-MONKEYS, Leukemia, 8(4), 1994, pp. 648-651
Authors:
VANGILS FCJM
BUDEL LM
BURGER H
VANLEEN RW
LOWENBERG B
WAGEMAKER G
Citation: Fcjm. Vangils et al., INTERLEUKIN-3 (IL-3) RECEPTORS ON RHESUS-MONKEY BONE-MARROW CELLS - SPECIES-SPECIFICITY OF HUMAN IL-3, BINDING CHARACTERISTICS, AND LACK OFCOMPETITION WITH GM-CSF, Experimental hematology, 22(3), 1994, pp. 248-255
Authors:
VANGILS FCJM
WESTERMAN Y
VANDENBOS C
BURGER H
VANLEEN RW
WAGEMAKER G
Citation: Fcjm. Vangils et al., PHARMACOKINETIC BASIS FOR OPTIMAL HEMATOPOIETIC EFFECTIVENESS OF HOMOLOGOUS IL-3 ADMINISTERED TO RHESUS-MONKEYS, Leukemia, 7(10), 1993, pp. 1602-1607
Authors:
MERTENS K
DONATH MJS
VANLEEN RW
DEKEYZERNELLEN MJM
VERBEET MP
BOS JMK
LEYTE A
VANMOURIK JA
Citation: K. Mertens et al., BIOLOGICAL-ACTIVITY OF RECOMBINANT FACTOR-VIII VARIANTS LACKING THE CENTRAL B-DOMAIN AND THE HEAVY-CHAIN SEQUENCE LYS713-ARG740 - DISCORDANT IN-VITRO AND IN-VIVO ACTIVITY, British Journal of Haematology, 85(1), 1993, pp. 133-142
Authors:
VANGILS FCJM
MULDER AH
VANDENBOS C
BURGER H
VANLEEN RW
WAGEMAKER G
Citation: Fcjm. Vangils et al., ACUTE SIDE-EFFECTS OF HOMOLOGOUS INTERLEUKIN-3 IN RHESUS-MONKEYS, The American journal of pathology, 143(6), 1993, pp. 1621-1633